期刊文献+

肝脏局灶性结节增生的临床诊治分析 被引量:6

Diagnosis and treatment of focal nodular hyperplasia of liver
原文传递
导出
摘要 目的探讨肝局灶性增生结节(FNH)的临床诊断与治疗。方法回顾性分析2006年1月至2011年7月收治的26例FNH病例的临床资料。结果26例中CT检查19例、其中平扫5例。结果14例呈低密度,5例呈等密度,10例病灶中央可见不规则低密度影,动脉期全部病灶均明显均匀强化。8例可见增粗的供血动脉,门脉期病灶密度有所下降,但仍高于肝实质,延迟期病灶呈等密度或略低于肝实质,7例中央瘢痕延迟强化。患者手术治疗22例,行左半肝4例、左外叶5例、肝部分切除13例。病理诊断为FNH,大多肿瘤质软,肉眼剖面呈较肝脏颜色略浅的棕色或黄褐色,部分病例可见中央瘢痕和放射状纤维间隔随访4个月-5年,未见复发。随诊观察4例,随访2-4年,未见增长。结论增强CT、MRI检查是FNH重要的诊断方法,手术切除是有效的治疗手段。 Objective To explore the diagnosis and treatment of focal nodular hyperplasia (FNH) of liver. Methods The clinical data were retrospectively analyzed for 26 cases with confirmed FNH of liver from January 2006 to July 2011. Enhanced computed tomography and magnetic resonance imaging were performed. Results Among them, 22 cases underwent surgical resection, including left hemihepatectomy ( n -- 4 ), left lateral lobe hepatectomy ( n --- 5 ) and partial hepatectomy ( n = 13 ). The pathological diagnosis was FNH. Most tumors were of soft texture. The gross surface was brown or yellow-brown in color. Central scar and radiating fibrous septas were spotted in some cases. There was no recurrence during a follow-up period of 4 months to 5 years. Serial observations were conducted for 4 cases with a follow-up period of 2 - 4 years. No growth was observed. Conclusions Enhanced CT and MRI are important diagnostic tools. The confirmed cases may be followed up. Surgical resection is effective with an excellent prognosis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第22期1556-1557,共2页 National Medical Journal of China
关键词 肝局灶性结节增生 诊断 治疗 Focal nodular hyperplasia, liver Diagnosis Treatment
  • 相关文献

参考文献2

二级参考文献38

  • 1沈英皓,樊嘉,吴志全,马曾辰,周信达,周俭,邱双健,钦伦秀,叶青海,孙惠川,黄晓武,汤钊猷.肝脏局灶性结节性增生60例临床分析[J].中华普通外科杂志,2005,20(7):397-399. 被引量:34
  • 2Shortell CK, Schwartz SI. Hepatic adenoraa and focal nodular hyperplasia [ J]. Surg Gynecol Obstet, 1991, 173 (5) : 426 -431.
  • 3Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal nodular hyperplasia of the liver [ J ]. Gastroenterology, 2000, 118(3) :560 -564.
  • 4Mergo PJ, Ros PR. Benign lesions of the liver [ J ].Radiol Clin North Am, 1998, 36(2) :319 -331.
  • 5Grantzdorffer I, LendeckelU, Carl - McGrath S, et al. Angiotensin Ⅰ- converting enzyme ( CD 143 ) is down - regulated in focal nodular hyperplasia of the liver [ J ] . Am J Surg Pathol, 2004, 28 ( 1 ) : 84 - 88.
  • 6Rocken C, Carl - McGrath S, Grantzdorffer I, et al. Ectopeptidases are differentially expressed in hepatoceUular carcinomas[J]. Int J Oncol, 2004, 24:487 -495.
  • 7Brancatelli G, Federle MP, Grazioli L, et al. Focal nodular hyperplasia : CT findings with emphasis on multiphasic helical CT in 78 patients[J]. Radiology, 2001,219(1) :61 - 68.
  • 8Grazioli L, Morana G, Kirchin MA, et al. MRI of focal nodular hyperplasia (FNH) with gadobenated in eglumine ( Gd - BOPTA ) and SPIO ( ferum oxides ) : an intra - individual comparison [ J ] . J Magn Reson Imaging, 2003 , 17 (3) : 593 -602.
  • 9Rahili A, Cai J, Trastour C, et al. Spontaneous rupture and hemorrhage of hepatic focal nodular hyperplasia in lobus caudatus [J]. J Hepatobiliary Pancreat Surg, 2005,12 ( 1 ) : 138 - 142.
  • 10Langrehr JM, Pfitzmann R, Hermann M, et al. Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia [J]. Acta Radiol,2006,47(1) :340-344.

共引文献19

同被引文献38

引证文献6

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部